Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
VERACYTE, INC. |
Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 26.05 USD | -1.21% | +2.66% | +8.93% | |
| Nov. 10 | Morgan Stanley Trims Price Target on Veracyte to $22 From $23, Maintains Underweight Rating | MT |
| Nov. 08 | Veracyte's Q3 Loss Widens, Revenue Increases; Raises 2023 Revenue Outlook | MT |
Chart calendar Veracyte, Inc.
919ebbe8d3.SepX8w-3FRMf_dQ1HKGdJUV6paABOSHREQCtJvd6CrA.AbA0xWfkf0NMnLpRUvvKZCELl-IsWxLnYjTOcNogRuB6rT6JevRyQ3i1lQ~9da1b0d909d85a55c91255392443c86b
Upcoming events on Veracyte, Inc.
Past events on Veracyte, Inc.
| 2023-11-15 03:00 pm | Stephens Investment Conference - Fireside Chat |
| 2023-11-07 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-03 | SITC Meeting - Abstract No - #782-C |
| 2023-11-03 | SITC Meeting - Abstract No - #70 |
| 2023-11-03 08:10 pm | SITC Meeting |
| 2023-10-03 05:30 pm | American Society for Radiation Oncology Meeting - Abstract No: 2825 |
| 2023-10-03 05:30 pm | American Society for Radiation Oncology Meeting - Abstract No: 2926 |
| 2023-10-02 | American Society for Radiation Oncology Meeting - Abstract No:2539 |
| 2023-10-02 06:20 pm | American Society for Radiation Oncology Meeting - Abstract No:159 |
| 2023-10-02 06:10 pm | American Society for Radiation Oncology Meeting - Abstract No:158 |
| 2023-10-01 07:55 pm | American Society for Radiation Oncology Meeting - Abstract No: 122 |
| 2023-09-28 10:00 am | American Thyroid Association Meeting - Poster No : 501 |
| 2023-09-28 10:00 am | American Thyroid Association Meeting - Poster No : 502 |
| 2023-09-28 10:00 am | American Thyroid Association Meeting - Poster No : 515 |
| 2023-09-12 04:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-08 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-08 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-21 | Next-Gen Immuno-Oncology Conference |
| 2023-06-18 09:30 am | Endocrine Society Meeting - Abstract No OR32 03 |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 92,0 90,7 1.46% | 120 120 0.13% | 117 116 1.49% | 220 215 2.27% | 297 291 1.79% | 353 |
|
EBITDA Million USD | Released Forecast Spread | -18,3 -20,7 11.62% | -11,0 -6,99 -57.46% | -27,4 -26,9 -2.06% | -62,3 -63,1 1.19% | -15,2 -21,8 30.46% | -22,5 |
|
EBIT Million USD | Released Forecast Spread | -22,2 -24,7 9.99% | -15,1 -11,2 -34.49% | -35,4 -33,0 -7.2% | -81,9 -79,4 -3.11% | -41,1 -47,0 12.67% | -56,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,0 -25,8 10.95% | -12,6 -9,15 -37.7% | -34,9 -33,1 -5.33% | -81,6 -84,9 3.78% | -36,4 -43,2 15.77% | -53,2 |
|
Net income Million USD | Released Forecast Spread | -23,0 -25,8 10.95% | -12,6 -9,07 -38.94% | -34,9 -33,0 -5.91% | -75,6 -79,0 4.3% | -36,6 -43,2 15.35% | -53,7 |
|
EPS USD | Released Forecast Spread | -0,62 -0,70 11.74% | -0,27 -0,20 -35% | -0,66 -0,63 -4.1% | -1,11 -1,16 3.96% | -0,51 -0,60 15.28% | -0,74 |
| Announcement Date | 25/02/19 | 25/02/20 | 17/02/21 | 28/02/22 | 22/02/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,4 54,2 11.38% | 67,3 62,5 7.73% | 67,8 61,9 9.48% | 72,9 68,1 7.02% | 75,6 66,4 13.83% | 80,3 74,9 7.18% | 82,4 75,7 8.81% | 90,3 83,1 8.71% | 90,1 84,4 6.78% | 89,9 | 92,1 | 97,3 | 99,5 | 103 |
|
EBITDA Million USD | Released Forecast Spread | -10,5 -12,4 14.71% | -5,93 -11,2 46.92% | -8,69 -15,3 43.13% | -4,24 -9,40 54.88% | -3,36 -10,6 68.34% | 1,14 -4,60 124.7% | -3,83 -0,30 -1176% | -1,19 -3,50 65.94% | -24,4 -1,30 -1778.15% | 3,00 | ||||
|
EBIT Million USD | Released Forecast Spread | -16,7 -11,0 -51.37% | -12,3 -11,7 -5.1% | -15,2 -18,0 15.42% | -10,7 -16,0 32.84% | -9,68 -17,2 43.78% | -5,42 -10,7 49.19% | -10,5 -8,61 -21.91% | -8,05 -11,0 26.88% | -31,7 -10,3 -209.14% | -7,08 | -4,69 | -3,70 | -4,34 | -1,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,5 -11,9 -30.08% | -11,3 -14,2 20.27% | -14,5 -18,8 23.1% | -9,65 -15,6 38.2% | -8,88 -16,8 47.31% | -3,44 -10,3 66.45% | -8,09 -9,45 14.37% | -8,28 -11,0 24.56% | -29,8 -11,3 -163.26% | -7,07 | -5,62 | -4,05 | -4,31 | -0,98 |
|
Net income Million USD | Released Forecast Spread | -14,1 -12,5 -13.26% | -10,5 -12,9 18.2% | -14,5 -17,8 18.86% | -9,53 -16,3 41.6% | -8,72 -17,5 50.11% | -3,84 -10,4 63.12% | -8,09 -9,91 18.38% | -8,40 -11,2 25.28% | -29,6 -11,5 -158.63% | -7,71 | -5,60 | -4,04 | -4,30 | -1,19 |
|
EPS USD | Released Forecast Spread | -0,20 -0,17 -20% | -0,14 -0,18 20.32% | -0,20 -0,25 20% | -0,13 -0,23 43.97% | -0,12 -0,25 52.76% | -0,05 -0,14 65.28% | -0,11 -0,14 23.61% | -0,12 -0,16 23.41% | -0,41 -0,16 -164.52% | -0,10 | -0,09 | -0,06 | -0,07 | -0,02 |
| Announcement Date | 11/09/21 | 02/28/22 | 05/03/22 | 08/02/22 | 11/02/22 | 02/22/23 | 05/04/23 | 08/08/23 | 11/07/23 | - | - | - | - | - |
| 2024-02-12 | Q4 2023 Earnings Release (Projected) |
| 2024-02-19 | Q4 2023 Earnings Release (Projected) |
| 2024-02-20 | Q4 2023 Earnings Release (Projected) |
| 2024-02-21 | Q4 2023 Earnings Release (Projected) |
| 2024-02-26 | Q4 2023 Earnings Release (Projected) |
| 2024-02-26 | Q4 2023 Earnings Release (Projected) |
| 2024-03-11 | Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | Q4 2023 Earnings Release (Projected) |
| 2024-04-22 | Q1 2024 Earnings Release (Projected) |
| 2024-04-24 | Q1 2024 Earnings Release (Projected) |
Past sector events for Veracyte, Inc.
| 2023-11-09 | Q3 2023 Earnings Release |
| 2023-11-09 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-07 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-06 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-01 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-27 | Q3 2023 Earnings Release |
| 2023-09-15 06:58 am | Q2 2023 Earnings Release |
| 2023-08-11 | Q2 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Veracyte, Inc. - Nasdaq
- Calendar Veracyte, Inc.